Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
WisdomTree
WT
$3.48B
| $3.57M | ﹤0.01% |
667,708
-319,813
| -32% | -$1.38M |
|
4152
PUT
SFL Corp
SFL
$1.65B
| $3.57M | ﹤0.01% |
568,300
+439,700
| +342% | +$3.04M |
|
4153
GFL Environmental
GFL
$15B
| $3.57M | ﹤0.01% |
122,247
-2,564,379
| -95% | -$62.8M |
|
4154
CALL
Vornado Realty Trust
VNO
$7.13B
| $3.57M | ﹤0.01% |
95,500
-124,500
| -57% | -$4.55M |
|
|
CURO
4155
DELISTED
CURO Group Holdings Corp.
CURO
| $3.57M | ﹤0.01% |
248,839
+174,996
| +237% | +$1.61M |
|
4156
CALL
CACI
CACI
$14.6B
| $3.56M | ﹤0.01% |
14,300
+7,800
| +120% | +$1.8M |
|
|
HDV
4157
iShares Core High Dividend ETF
HDV
$15B
| $3.56M | ﹤0.01% |
202,825
-1,240
| -0.6% | -$21K |
|
4158
Levi Strauss
LEVI
$8.58B
| $3.56M | ﹤0.01% |
177,095
-127,284
| -42% | -$2.28M |
|
4159
PUT
Urban Outfitters
URBN
$6.61B
| $3.56M | ﹤0.01% |
138,900
+47,700
| +52% | +$1.23M |
|
4160
Deluxe
DLX
$1.1B
| $3.55M | ﹤0.01% |
121,627
+82,275
| +209% | +$2.12M |
|
4161
CALL
Momentus
MNTS
$89.7M
| $3.55M | ﹤0.01% |
+16
| New | +$2.51M |
|
4162
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.1B
| $3.55M | ﹤0.01% |
76,936
+9,790
| +15% | +$427K |
|
4163
Vanguard Extended Market ETF
VXF
$32.3B
| $3.54M | ﹤0.01% |
+21,527
| New | +$3.19M |
|
4164
CALL
FMC
FMC
$1.25B
| $3.54M | ﹤0.01% |
30,800
+900
| +3% | +$100K |
|
4165
CALL
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.43B
| $3.54M | ﹤0.01% |
94,200
+22,800
| +32% | +$816K |
|
4166
Bentley Systems
BSY
$10.5B
| $3.54M | ﹤0.01% |
87,344
+11,690
| +15% | +$414K |
|
4167
PUT
Invesco DB Agriculture Fund
DBA
$1.21B
| $3.54M | ﹤0.01% |
219,100
+132,700
| +154% | +$2.01M |
|
|
ITCI
4168
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.53M | ﹤0.01% |
111,100
-53,100
| -32% | -$1.4M |
|
4169
CALL
Herbalife
HLF
$1.26B
| $3.53M | ﹤0.01% |
73,500
+10,100
| +16% | +$487K |
|
|
BLU
4170
DELISTED
BELLUS Health Inc.
BLU
| $3.53M | ﹤0.01% |
1,153,755
+205,974
| +22% | +$558K |
|
4171
Patrick Industries
PATK
$2.75B
| $3.53M | ﹤0.01% |
77,388
-56,006
| -42% | -$2.37M |
|
4172
PUT
Huntington Bancshares
HBAN
$36.5B
| $3.53M | ﹤0.01% |
279,200
+43,500
| +18% | +$494K |
|
4173
Lattice Semiconductor
LSCC
$19.1B
| $3.52M | ﹤0.01% |
76,912
+43,869
| +133% | +$1.7M |
|
|
IGMS
4174
PUT
DELISTED
IGM Biosciences
IGMS
| $3.52M | ﹤0.01% |
39,900
+33,100
| +487% | +$2.33M |
|
|
CS
4175
DELISTED
Credit Suisse Group
CS
| $3.52M | ﹤0.01% |
275,260
-917,819
| -77% | -$10.6M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.